Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
Active & Responsive
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
for
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm,
Location: Duarte CA, Santa Monica CA, Stanford CA, Houston TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07114601
Phase 1, Recruiting
Active & Responsive
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
for
Breast Cancer, Endometrial Cancer, Ovarian Cancer,
Location: Duarte CA, Irvine CA, West Valley City UT,
Sponsor: Terremoto Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07109726
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
for
Acute Myeloid Leukemia
Location: Duarte CA, Stanford CA, Phoenix AZ, Salt Lake City UT,
Sponsor: Norman J. Lacayo
Sex: All
Age: 0 - 21
Code: NCT05101551
Phase 1, Recruiting
Active & Responsive
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Location: Duarte CA, Denver CO, Aurora CO, Austin TX,
Sponsor: Marker Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05798897
Phase 1, Recruiting
Active & Responsive
Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
for
CLL/SLL
Location: Duarte CA, Seattle WA, Cleveland OH, Canton OH,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18 - 70+
Code: NCT04215809
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Duarte CA, Los Angeles CA, Long Beach CA, Orange CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase 3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Duarte CA, Los Angeles CA, Beverly Hills CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
Pancreatic Cancer Detection Consortium
for
Pancreatic Cancer, Pancreatic Carcinoma,
Location: Monrovia CA, Phoenix AZ, Tacoma WA, Peoria IL,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06388967
Recruiting
Active & Responsive
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
for
Metastatic Lung Non-Small Cell Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07619599
Phase 1, Recruiting
Active & Responsive
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
for
Opioid Use Disorder, Opioid Use Disorder, Severe,
Location: Los Angeles CA, Grants Pass OR, Roswell NM,
Sponsor: Montefiore Medical Center
Sex: All
Age: 18+
Code: NCT07631598
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
for
Bipolar-I Disorder With Mania or Mania With Mixed Features
Location: Los Angeles CA, Bellflower CA, Montclair CA, Anaheim CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06951698
Phase 3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Los Angeles CA, Long Beach CA, Pomona CA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
for
Venous Leg Ulcer (VLU)
Location: Los Angeles CA, Vista CA, Fresno CA, San Francisco CA,
Sponsor: MediWound Ltd
Sex: All
Age: 18+
Code: NCT06568627
Phase 3, Recruiting
Active & Responsive
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Location: Burbank CA, Santa Maria CA, Arroyo Grande CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07018869
Phase 3, Recruiting
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
for
Plasma Cell Myeloma
Location: Burbank CA, Santa Maria CA, Arroyo Grande CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT05561387
Phase 3, Recruiting
Active & Responsive
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
for
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
Location: Burbank CA, Santa Maria CA, Arroyo Grande CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07091617
Recruiting
Active & Responsive
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
for
Non-small Cell Lung Cancer, NSCLC
Location: Burbank CA, San Diego CA, Grand Junction CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06422143
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis